Recall Ledger

Fesoterodine Fumarate recall (Alembic Pharmaceuticals Limited)

DrugClass IIIOngoing

Summary: Alembic Pharmaceuticals Limited is recalling Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-176-30. Reason: Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

What is being recalled

Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-176-30

Why

Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

How serious is it

Class III is the least serious level: using or being exposed to this product is not likely to cause health problems, but it breaks FDA rules.

Where it was sold

US Nationwide and PR. (states named: Puerto Rico)

How to tell if yours is affected

Lot# 2405003360, Exp Date: Jan 31, 2026

What to do

Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.

Recall facts

Recall numberD-0248-2026
CategoryDrug
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass III
StatusOngoing
Recall startedDecember 16, 2025
ReportedJanuary 14, 2026
CompanyAlembic Pharmaceuticals Limited
Company locationPanchmahal, India
Initiated byVoluntary: Firm initiated

More recalls from Alembic Pharmaceuticals Limited · all drug recalls · recalls from December 2025

Official FDA record